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Abstract
Background: The prevalence of phantom limb pain (PLP) in people with amputations is unclear because of the
conflicting reports across the literature. It is proposed that the conflicting reports on the prevalence of PLP are a
consequence of variations in the time period during which the studies were undertaken, countries in which the
studies were conducted and recruitment processes implemented during collection of epidemiological data. In
consideration of these factors, we aim to gather and critically appraise relevant literature to determine the
prevalence estimate of and risk factors for PLP in people with amputations.
Methods: We will use a customised search strategy containing relevant words and terms to search the following
databases: MEDLINE/PubMed (via EBSCOhost), PsycINFO (via EBSCOhost), PsycArticles, Cumulative Index to Nursing
and Allied Health Literature (CINAHL) (via EBSCOhost), Africa-Wide Information (via EBSCOhost), Health Source:
Nursing/Academic Edition (via EBSCOhost) SCOPUS, Web of Science and Academic Search Premier (via EBSCOhost).
The risk of bias assessment will be conducted using a risk of bias assessment tool for prevalence studies, and data
will be extracted using a piloted customised data extraction sheet. Data extracted from individual studies will be
entered into Review Manager 5 and assessed for clinical and statistical heterogeneity. Studies will be pooled for
meta-analysis using the random-effects model to determine a summary estimate of the prevalence of PLP across
included studies. A statistically significant level will be set at p < 0.05.
Discussion: As far as we know, a systematic review and meta-analysis on the prevalence of, and risk factors for PLP
in people with amputations has not been conducted. Given the varying reports in the literature, it is necessary to
determine an estimate of the prevalence of PLP to generate an informed conclusion on this subject. The results of
this review will be published in an internationally accredited journal and used to inform researchers, clinicians,
policy-makers and the public about the burden of, and risk factors for PLP. This will be done with a further aim to
improve the quality of pain management in society.
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Background
Phantom limb pain (PLP) is defined as pain felt in the
missing portion of the amputated limb following amputa-
tion [1]. Phantom limb pain commonly occurs in people
with limb amputations due to trauma or surgery. How-
ever, some cases of PLP have been reported in congenital
amputees [2, 3]. It has been proposed that risk factors
such as persisting pre-operative pain, stump pain and time
period since amputation contribute to the onset of PLP
[4]. Phantom limb pain remains a serious public health
problem because it is common and often undertreated [5].
As a result, persisting PLP may contribute further to
depression and problems with prosthesis use, sleep and
participation in activities of daily function [1, 6, 7].
The prevalence of PLP among people with amputation
is unclear, perhaps because of conflicting reports across
the literature. While some studies report a high prevalence
of 85% [8, 9], one study has reported a markedly lower
prevalence of 33% [10]. The conflicting reports in the
literature regarding the prevalence of PLP is perplexing. It
has been proposed that such discrepancy is likely caused
by a variation in the time period during which the studies
were undertaken, the countries in which the studies were
conducted and the recruitment processes implemented
during collection of epidemiological data [11].
Early studies, conducted during a period when PLP
was commonly characterised as a psychiatric disorder,
reported low prevalence rates [12]. Perhaps low rates
could be accounted for by the patients’ fear of reporting
their pain to avoid the stigma associated to PLP. Low
prevalence rates are also recorded in studies conducted
in developing countries where the stigma associated with
chronic pain conditions is still common [13]. Finally,
many prevalence studies of PLP were conducted in
clinical settings using patients continuing with medical
care, introducing a recruitment bias [10, 14–17]. Thus,
patients without access to clinical care may be unaccounted
for in these statistics.
Prevalence studies are key to informing researchers,
clinicians, policy-makers and the public about the burden
of disease in society [18]. However, a wide variation in the
reported prevalence of PLP does not provide a definitive
prevalence estimate, and therefore hinders the develop-
ment or implementation of effective interventions for
preventing or treating PLP. Further, up to date, there is no
systematic review that has synthesised data on the risk
factors for PLP. To address this gap in the literature, a
systematic review and meta-analysis will be conducted by
gathering and critically appraising relevant literature regard-
ing the prevalence of, and risk factors for PLP in people
with amputations. The results of this review will enable us
to generate an evidence-informed conclusion on the preva-
lence estimate of PLP, as well as associated risk factors in
people with amputations. Further, they will be used to
motivate for the development and implementation of prag-
matic interventions that may prevent or reduce PLP in
people with amputation. The current evidence suggests that
rehabilitation approaches rather than pharmacological ap-
proaches are most effective for treating PLP [19]. Therefore,
the results of this review may also highlight the need for
enough access not only to medication but also to physio-
therapists and occupational therapists for the treatment
of PLP.
Objective
The purpose of this review will be to determine the
prevalence estimate of and risk factors for PLP in people
with amputations. In addition, this review will determine
if there is an association between the prevalence of PLP
and the development status (developed vs developing) of
countries in which the studies were conducted.
Methods
This protocol was developed in accordance with the
Preferred Reporting Items of Systematic Reviews and
Meta-Analysis Protocol (PRISMA-P) guidelines [20], and
has been registered on PROSPERO—an international pro-
spective register of systematic reviews with health-related
outcome [21]. The PRISMA-P guidelines fulfilled by this
protocol are presented in Additional file 1.
Criteria for selecting studies for this review
Inclusion criteria
– Study design and participants: published and
unpublished prevalence case-control, cross-sectional
and cohort studies on PLP in surgical, traumatic and
congenital amputees aged ≥ 18 years.
– Outcome: prevalence of PLP and/or risk factors
for PLP.
– Study setting: clinical and community-based studies
conducted worldwide.




– Intervention (only) studies.
Search strategy for identification of studies
Electronic searches
One investigator (KL) and a senior medical librarian will
use a customised search strategy (Appendix) containing
appropriate words and terms to search the following
databases: MEDLINE/PubMed (via EBSCOhost), PsycINFO
(via EBSCOhost), PsycArticles, Cumulative Index to
Nursing and Allied Health Literature (CINAHL) (via
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EBSCOhost), Africa-Wide Information (via EBSCOhost),
Health Source: Nursing/Academic Edition (via EBSCOhost)
SCOPUS, Web of Science and Academic Search Premier
(via EBSCOhost). Studies identified from this electronic
search will be saved on EndNote X8 programme, which will
also be used to remove duplicates [22].
Search of other sources
We will search the reference list of all eligible studies to
identify additional studies with the potential for inclusion
in this review. To identify grey literature, we will search
OpenGrey www.opengrey.eu, and contact experts on
ResearchGate www.researchgate.net to seek unpublished,
and ongoing studies that may be eligible for inclusion.
Data collection and analysis
Study screening
Following the removal of duplicates, retained studies will
be transferred to the Covidence systematic review soft-
ware available at www.covidence.org. This software will
be used as an online collaboration platform for reviewers
during the entire screening process. Two reviewers (KL
and GJB) will independently screen study titles and
abstracts for eligibility. Two reviewers (KL and GJB)
will independently assess full-text articles retained from
the initial screening for eligibility using the inclusion
and exclusion criteria. The entire review process will be
illustrated using a PRISMA flowchart detailing included
studies and excluded studies, with reasons for their
exclusion.
Data extraction and management
Two reviewers (KL and GJB) will independently extract
data using a piloted customised data extraction sheet.
The following data will be extracted: authors, year of
publication, study setting, country of study, sample size,
participants’ age and gender, site of amputation, PLP
prevalence and risk factors, and author conflict of interest
statement. Completed data extraction forms will be stored
on a password-protected online storage platform which
will be accessible only to the reviewers. Any disagreements
between reviewers will be resolved by discussion. A third
reviewer (RP) will be consulted if a consensus cannot be
reached.
Risk of bias assessment
Two reviewers (KL and GJB) will independently conduct
a risk of bias assessment using a risk of bias assessment
tool for prevalence studies developed by Hoy et al. [23].
The results of this assessment will be classified as either
low, moderate or high risk. Any disagreements between
reviewers will be resolved by discussion. A third reviewer
(VJM) will be consulted if a consensus cannot be reached.
Data analysis
Data extracted from individual studies will be entered
into Review Manager 5 [24] for analysis. Clinical het-
erogeneity will be determined based on similarities or
differences in participant and outcome characteristics,
recruitment procedures and study setting [25]. Statis-
tical heterogeneity will be assessed using the I2 statistic,
and the results will be presented as low (< 25%), moderate
(25–50%) and high (> 50%) [26]. Subject to consideration
of heterogeneity and risk of bias, studies will be pooled for
meta-analysis using the random-effects model to deter-
mine a summary estimate of PLP prevalence across
included studies. A statistically significant level will be set at
p < 0.05. A narrative data analysis will be conducted where
there is insufficient data to conduct a meta-analysis. A fun-
nel plot will be generated to assess for possible publication
bias [27]. In addition, the Egger’s regression test will be
used to assess for the asymmetry of the funnel plot. A sig-
nificant result (p < 0.05) will indicate a possible publication
bias [27]. Risk factors for PLP will be identified from
included studies and synthesised descriptively. Cohen’s
Kappa will be used to determine inter-rater agreement
during screening, data extraction and risk of bias assess-
ment as either minimal (0–0.39), weak (0.40–0.59), sub-
stantial (0.60–0.79) or strong (0.80–0.90) [28].
Subgroup analysis
A subgroup analysis on the prevalence of PLP will be
conducted based on the development status of the countries
in which the studies were conducted. Each country will be
allocated to either group (developing vs developed) using
the World Economic Situation and Prospects (WESP)
classification system [29]. Vascular complications are
the common cause of amputations in developed countries
and traumatic accidents are the common cause of ampu-
tations in developing countries [30–32]. Regardless of the
differences in the reasons for amputations, recent evi-
dence shows that there is a similar number of limb ampu-
tations conducted in developing and developed countries
[33, 34]. However, it is unclear whether there is a difference
in the reported prevalence of PLP between developing and
developed countries. The purpose of this subgroup analysis
is to determine if this is the case.
Grading the certainty of evidence
The Grading of Recommendations Assessment, Devel-
opment, and Evaluation (GRADE) methodology will be
used to determine the certainty of evidence regarding
the prevalence of PLP. The quality of evidence will be
graded as high if further research is unlikely to change
the effect estimates, moderate if further research is likely
to have a considerable impact on the effect estimates
and low if further research is likely to be capable of
changing the effect estimates [35].
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Dealing with missing data
We will contact the authors of included studies to request
missing data as necessary. If additional data cannot be
obtained, each study with incomplete data will not be
analysed.
Discussion
As far as we know, a systematic review and meta-ana-
lysis on the prevalence of and risk factors for PLP in
people with amputations has not been conducted. Given
the conflicting reports in the literature concerning the
prevalence of PLP, it is necessary to determine the esti-
mate of the prevalence of PLP to generate an informed
conclusion on this subject. The results of this review will
be published in a peer-reviewed journal and used to in-
form researchers, clinicians, policy-makers and the public
about the burden of PLP in society. Further, they will be
used to motivate for the development and implementation
of pragmatic interventions that could prevent or reduce
PLP in people with amputation. By clarifying risk factors
for PLP, this study will provide empirical evidence that
may enable clinicians to identify priorities for diagnosing,
treating and preventing PLP.
Appendix
Search strategy [PubMed]
1. Amputation [MeSH] OR Amputation, Traumatic
[MeSH] OR Amputation Stumps [MeSH] OR
Amputee OR amputees OR amputation OR limb
deficiency OR limb loss.
2. Phantom Limb [MeSH] OR Phantom limb OR
phantom pain OR phantom sensations OR
phantom sensation OR residual limb pain
3. Epidemiology [MeSH] OR Epidemiology
[Subheading] OR Prevalence [MeSH] OR Risk
Factors [MeSH]
4. associated OR association OR burden OR
case-control OR cohort OR correlation OR
correlates OR cross-sectional OR determinant OR
epidemiology OR epidemiological OR epidemiologic
OR frequency OR incidence OR interview OR
likelihood ratio OR observational OR occur OR
occurrence OR odds ratios OR predict OR
predictor OR prediction OR present OR
presentation OR prevalence OR prevalent OR
probability OR prognosis OR prognostic OR
proportion OR prospective OR questionnaire OR
questionnaires OR rate OR retrospective OR risk
OR risks OR self-report OR statistic OR surveillance
OR survey OR surveys
5. 1 AND 2 AND 3 AND 4
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Additional file 1: PRISMA-P Checklist. (DOCX 30 kb)
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